Purpose and Benefits Sunitinib Malate Capsules are formulated to support the treatment of various types of cancers, including renal cell carcinoma, gastrointestinal stromal tumor, and pancreatic neuroendocrine tumors. They are specifically designed for individuals seeking to manamore...
Treatment : Used to Treat Adults with Certain Types of Gastrointestinal Stromal Tumors,
Form : Capsules
Storage : Cool and Dry Place
Best Before : 36 Months from Manufacturing
Dosage : As per Doctor's Prescription
On November 16, 2017, the Food and Drug Administration approved sunitinib malate for the adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma following nephrectomy.On November 16, 2017, the Food and Drug Administration approved sunitinib malate (Sutmore...